VAERS reports by lot

GSK Varicella/Shingles lot 992H3: VAERS reports

35 VAERS reports list lot 992H3 as a GSK Varicella/Shingles vaccine, received between 2018-12-28 and 2021-11-23. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
35
Reports
3%
Marked serious
0
With a death outcome
10
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)3030%
Injection-site / Local reaction2929%
Neurological1414%
Musculoskeletal99%
Dermatological (non-injection-site)66%
Allergic / Anaphylactic44%
Cardiac / Cardiovascular33%
Autoimmune / Immune-mediated22%
Respiratory11%
Gastrointestinal11%
Psychiatric / Neuropsychiatric11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Virginia6
Wisconsin3
New York3
Pennsylvania2
Hawaii2
Indiana2
Michigan2
Massachusetts2
South Dakota2
Utah1
Vermont1
South Carolina1

Reports by month received

2018-125
2019-0111
2019-023
2019-035
2019-043
2019-053
2019-061
2019-081
2020-021
2021-112

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.